Back

Choose your region

FamiCord News

FamiCord News

Search:

  • Groundbreaking: NO MORE LIMITATIONS FOR CORD BLOOD USE On 17 April 2023, the FDA gave approval to the Gamida Cell product “Omisirge” (known also as omidubicel or NiCord)… Read more
  • FamiCord enters United Kingdom and expands outside Europe Polski Bank Komórek Macierzystych S.A. (PBKM), which leads the international FamiCord Group, Europe’s largest stem cell bank, signed a transaction agreement with… Read more
  • Completion of the 1st phase inventory check of biological material samples stored originally by former service provider This information is addressed to the customers of former service provider in connection with which we have been authorized as a contact point for the customers of former service provider… Read more
  • The FamiCord Group strengthens its position in Turkey The FamiCord Group strengthens its position in Turkey by investing in a stem cell bank belonging to the Acıbadem Healthcare Group… Read more
  • Letter of intent between Medical University of Warsaw (WUM) and FamiCordTx signed Rector of the Medical University of Warsaw prof. Mirosław Wielgoś and representatives of the FamiCordTx company: Dr Tomasz Baran – President of the Management Board and Dr Tomasz Ołdak – Member of the Management Board – signed aletter of intent regarding cooperation in the field of development and i… Read more
  • FamiCord is number 1 in Europe and number 5 in the World According to recent publication by Parents Guide Cord Blood Foundation – FamiCord Group, founded by Polski Bank Komórek Macierzystych (PBKM), proudly stands as… Read more